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As vascular laboratories become more experi-
enced in the use of color flow duplex imaging, the
diagnosis of isolated calf vein thrombosis (ICVT) is
made with increasing frequency. It is known that
approximately 9% to 20% of ICVT will propagate
to involve the more proximal deep veins,1 and we
have reported that a number of patients with ICVT
and pulmonary symptoms have pulmonary
emboli.2
Although numerous studies have documented
the late clinical and hemodynamic sequelae of prox-
imal venous thrombi,3-5 little information is avail-
able after ICVT. To determine the long-term seque-
lae of ICVT, we performed clinical and lower
extremity hemodynamic testing in a cohort of
patients identified by color flow duplex scanning
between 1989 and 1994 as having ICVT. A group
of subjects without signs or symptoms of venous dis-
ease and no history of venous thrombosis also
underwent venous hemodynamic testing and served
as control subjects.
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Purpose: Despite the frequent occurrence of isolated calf vein thrombosis (ICVT), little
is known about the long-term clinical and hemodynamic sequelae of this condition. This
study was conducted to determine late clinical symptoms and vascular laboratory abnor-
malities in patients after ICVT.
Methods: Of 146 patients in whom ICVT was documented by color flow duplex scanning
between 1989 and 1994, 37 were reexamined. Data included history, physical examination,
venous recovery time (VRT), and duplex valve closure time (DVCT). A control group with
no history of venous disease also underwent identical clinical and hemodynamic testing.
Results: Thirty-seven patients (18 male and 19 female) with a median age of 56 years
(range, 22 to 76 years) were examined at a mean follow-up of 3.4 years (range, 2.2 to 5.8
years) after the diagnosis of ICVT in 39 extremities. Seventeen subjects (34 extremities)
were recruited as normal controls. Presenting symptoms at the time of ICVT included
calf pain in 17 patients, calf swelling in seven, pain and swelling in seven, pulmonary
symptoms in four, pulmonary symptoms and calf pain in one, and no symptoms in one.
In the patients with ICVT, VRT was abnormal in 23% of extremities with ICVT and in
9% of extremities without ICVT. None of the extremities in the control group had an
abnormal VRT (p < 0.05). DVCT was abnormal in one or more venous segments in 26%
of extremities diagnosed with ICVT and in 6% of control extremities (p < 0.05). Follow-
up clinical examination in patients with ICVT revealed 13 (35%) with reticular veins, 10
(27%) with varicose veins, two (5.4%) with edema, one (2.7%) with pigmentation and
ulcer (contralateral extremity to ICVT with a previous history of proximal deep venous
thrombosis), 13 (35%) with mild discomfort, and one (2.7%) with severe pain. All symp-
toms attributable to ICVT were mild in nature except in one patient who had severe pain
and no physical or hemodynamic vascular laboratory abnormalities at follow-up.
Conclusion: At an average of 3.4 years after ICVT, approximately one third of patients
showed evidence of mild to moderate venous valvular insufficiency, but mostly in seg-
ments not involved with ICVT, and few had significant clinical symptoms attributable
to venous disease.  (J Vasc Surg 1998;27:50-7.)
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MATERIALS AND METHODS
Patient selection. Patients diagnosed with
ICVT by color flow duplex ultrasound were identi-
fied by review of vascular laboratory charts between
1989 and 1994 from the vascular laboratories at the
Oregon Health Sciences University (OHSU) and
Providence Medical Center Hospitals in Portland,
Oregon. Both vascular laboratories are staffed by
OHSU-employed registered vascular technologists
under the supervision of the Division of Vascular
Surgery at OHSU and are accredited by the
Intersocietal Commission for the Accreditation of
Vascular Laboratories (ICAVL). All patients who
agreed to participate and in whom a subsequent
venous thrombosis had not been diagnosed were
included in the study. The study was approved by
the Institutional Review Boards of OHSU and
Providence Medical Center Hospitals. All follow-up
studies were performed at the OHSU vascular labo-
ratory, and all patients signed informed consent.
A separate group of seven men and 10 women
between the ages of 25 and 65 years with no histo-
ry or signs or symptoms of venous disease were
recruited as control subjects from employees at the
OHSU Hospital and also underwent history, physi-
cal examination, and vascular laboratory venous
hemodynamic testing. The purpose of the control
group was to verify specificity of the duplex valve
closure time and photoplethysmographic venous
recovery time (VRT) examination in patients with
no history or evidence of venous disease.
Patient interview and examination. Patients
and control subjects were initially assessed using a
standard questionnaire. Each patient was queried
with regard to a history of deep venous thrombosis
(DVT) before the development of the ICVT, risk
factors temporally related to the initial ICVT, symp-
toms before and after ICVT, and past or ongoing
treatment for ICVT.
Physical examination of patients and control sub-
jects included inspection of the lower extremities in
both the supine and standing position, with special
attention to the presence of telangiectasias or reticu-
lar veins, varicose veins, edema, pigmentation, lipo-
dermatosclerosis, ulcer scarring, and active ulcera-
tion of both lower extremities. Patients were
assigned a clinical classification as suggested in
“Reporting standards in venous disease”6 (Table
I).In addition, a disability score was also assigned
(Table II).7
Vascular laboratory examination. All patients
and control subjects underwent bilateral lower
extremity venous hemodynamic testing for assess-
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ment of reflux. Venous reflux was assessed by VRT
and segmental duplex ultrasound evaluation of
venous valve closure time (DVCT).
VRTs were determined by photoplethysmogra-
phy. A transducer (Vascular Lab, Medsonics,
Fremont, Calif.) was attached to the skin 5 cm prox-
imal to the medial malleolus on both legs. Ten tip-
toe dorsiflexions were done without application of
segmental venous tourniquet. The VRT was consid-
ered abnormal if 95% of the refill time was less than
18 seconds. If the VRT was less than 18 seconds
then repeat testing was performed with a segmental
venous tourniquet.8
DVCT was performed using a color flow duplex
scanner (Acuson 128 XP-10, Mountain View, Calif.)
and the distal cuff deflation technique described by
van Bemmelen et al.9 Five venous segments were
examined in each extremity according to our stan-
dard vascular laboratory protocol. These included
the common femoral vein, popliteal vein, posterior
tibial vein, greater saphenous vein at the saphe-
nofemoral junction, and the lesser saphenous vein.
This is the standard protocol used by our laboratory
and is based on previously published protocols for
evaluating venous reflux with DVCT.10,11
Retrograde venous flow greater than 0.5 seconds
after cuff deflation was defined as indicating abnor-
mal venous reflux.
Statistical methods. Comparison of two pro-
portions was used to compare percent abnormality
in the aforementioned vascular laboratory tests in
lower extremities with ICVT to control extremities.
A p value less than 0.05 was considered significant.
RESULTS
Demographics
Between 1989 and 1994, 146 patients were
diagnosed with ICVT. Of these, 57 (39.0%) were
lost to follow-up, 24 (16.4%) were dead at follow-
up, 28 (19.2%) refused to participate in the study,
and 37 patients (25.4%; 18 male, 19 female) with 39
extremities in which ICVT was diagnosed were
enrolled in the study. All patients underwent color
flow duplex ultrasound examination of both extrem-
ities at the time of ICVT diagnosis, thereby exclud-
ing thrombosis, but not reflux, in all other ipsilater-
al and contralateral superficial and deep veins. The
patients’ median age at diagnosis was 56 years
(range, 22 to 77 years), and the mean time to fol-
low-up examination was 3.4 years (range, 2.2 to 5.8
years). At the time of diagnosis of ICVT, 17 patients
complained of calf pain only, seven of leg swelling
only, seven of lower extremity pain and swelling,
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four of pulmonary symptoms, and one of pulmonary
symptoms and calf pain. One ICVT was found on a
postoperative surveillance study. ICVT was confined
to 19 posterior tibial veins (44.2%), 22 peroneal
veins (51.2%), and two anterior tibial veins (4.6%).
Four patients had two calf vein thromboses in one
leg. Seventeen subjects with no prior history of DVT
or varicose veins were recruited as control subjects
(7 male and 10 female) with a median age of 53
years (range, 25 to 65 years).
Risk factors and treatment
Risk factors temporally associated with the onset
of ICVT are shown in Table III. Six patients had a
history of DVT in the contralateral lower extremity.
One patient who had ICVT in both extremities had
a history of superficial venous thrombosis in one
lower extremity. All patients had at least one risk fac-
tor; three patients had one risk factor, 15 had two
risk factors, 12 had three risk factors, six had four
risk factors, and one had five risk factors (mean, 2.6
risk factors per patient). Normal control subjects (n
= 17) had no risk factors for DVT except that 60%
were older than 40 years of age.
Nineteen patients (51%) were treated with
heparin anticoagulation followed by warfarin. Three
patients were given anticoagulation medication for
less than 6 weeks, four patients for 6 to 12 weeks,
five patients for 3 to 6 months, two patients for 6
months to 1 year, and five patients indefinitely. Eight
patients (22%) were treated with aspirin. Seventeen
patients (46%) wore compression stockings for a
mean of 7.3 months. Four patients (11%) continued
to wear compression stockings at follow-up. No
patient had a clinically suspected DVT in either
extremity between the time of their initial ICVT and
follow-up examination.
Vascular laboratory studies
VRT. VRTs were normal (>18 seconds) in all 34
lower extremities of the 17 control subjects. In the
37 patients with ICVT, 12 lower extremities had an
abnormal VRT. Of these 12 lower extremities with
an abnormal VRT, nine were limbs with ICVT and
three were limbs without DVT at the time of the
diagnosis of ICVT in the contralateral leg. All but
two extremities corrected after segmental tourni-
quets were applied. The prevalence of an extremity
with an abnormal VRT was significantly higher in
the patients with ICVT than in the control subjects
(p = 0.009).
DVCT. Thirty-six of the 37 patients with ICVT
underwent assessment of DVCTs. This included 38
lower extremities with ICVT and 34 without calf
vein or proximal DVT at the time of the patient’s
initial diagnosis of ICVT. One patient could not be
studied with duplex scanning because of physical
limitations. All lower extremities (n = 34) in the con-
trol subjects were studied with duplex for determi-
nation of DVCTs.
Overall, 11 of the 36 patients (31%) with ICVT
studied in follow-up with duplex had at least one
lower extremity with one or more venous segments
with an abnormal DVCT. Two of the 17 control
subjects (12%) had at least one lower extremity with
one or more venous segments with an abnormal
DVCT. The likelihood of a patient having a lower
extremity with at least one venous segment with an
abnormal DVCT was no different in the patients
with a history of ICVT than in the control subjects
(p = 0.23).
The presence of an ICVT in a lower extremity
did, however, effect the likelihood of detecting an
abnormal DVCT in that extremity. Ten of the 38
lower extremities (26%) with an ICVT studied with
duplex scanning in follow-up had at least one venous
segment with an abnormal DVCT. In these same
patients, five of the 34 contralateral lower extremi-
ties (14%) without ICVT at the time of diagnosis of
Table I. Clinical classification of chronic lower
extremity venous disease
Class Physical signs
0 No visible or palpable signs of venous disease
1 Telangiectasias, reticular veins, malleolar flare
2 Varicose veins
3 Edema without skin changes
4 Skin changes ascribed to venous disease (e.g., pig-
mentation, venous eczema, lipodermatosclerosis)
5 Skin changes as defined above with healed ulceration
6 Skin changes as defined above with active ulceration
From: Porter JM, Moneta GL, International Consensus
Committee on Chronic Venous Disease. J Vasc Surg
1995;21:635-45.6
Table II. Venous dysfunction disability score classi-
fication
Class Level of disability
0 Asymptomatic
1 Symptomatic; can function without a support device
2 Can work 8-hour day only with support device
3 Unable to work even with support device
From the Executive Committee of Ad Hoc Committee,
American Venous Forum.7
JOURNAL OF VASCULAR SURGERY
Volume 27, Number 1 McLafferty et al. 53
ICVT also were found to have one or more venous
segments with an abnormal DVCT. Only two of the
34 lower extremities (6%) in the control subjects had
one or more venous segments with an abnormal
DVCT. The likelihood of having an abnormal
DVCT at follow-up in a lower extremity with a pre-
vious ICVT was significantly higher than the likeli-
hood of having an abnormal DVCT in a lower
extremity from a control subject (p = 0.05). In the
lower extremities not affected by DVT in the
patients with ICVT, the likelihood of having at least
one venous segment with an abnormal DVCT was
no different than the likelihood of having at least
one venous segment with an abnormal DVCT in a
lower extremity of a control subject (p = 0.43).
Table IV details the locations of the abnormal
DVCTs in the five individual venous segments stud-
ied in the effected and unaffected lower extremities
of the patients with ICVT and in the lower extrem-
ities of the control subjects. Abnormal DVCTs were
found less often in venous segments of control lower
extremities (1.7%) than in the affected (7.4%; p =
0.01) and unaffected (7.6%; p = 0.01) lower extrem-
ities of the patients with ICVT. After eliminating
unaffected extremities that had a history of DVT
before ICVT, 2.1% of venous segments were abnor-
mal in the unaffected extremities (p = 0.87 com-
pared with control extremities).
Only 5% of the extremities with ICVT had an
abnormal DVCT in their posterior tibial vein (Table
IV). Abnormal valve closure times were, however,
detected at all locations in the subjects with ICVT.
The large majority (25 of 27; 93%) of venous seg-
ments with abnormal valve closure times in the
patients with ICVT were located in ipsilateral sites
other than the posterior tibial vein of the extremity
with ICVT or were located in the contralateral unaf-
fected lower extremity.
Clinical classification and disability score
Overall symptoms and signs of chronic venous
insufficiency were minimal, as was disability caused
by chronic venous insufficiency. Eleven patients
(30%) had no physical findings of chronic venous
disease and were therefore clinical class 0 (Table I).
Of the remaining 26 patients, 13 were clinical class
1, 10 clinical class 2, two clinical class 3, and one
clinical class 6. The clinical class 6 patient had severe
chronic venous disease with lipodermatosclerosis
and a small venous ulcer. However, the symptomatic
extremity was opposite that of the ICVT and had
had a previous proximal DVT.
Twenty-three of the 37 patients (62%) with
ICVT were entirely asymptomatic, with a disability
score of 0 (Table II). Of the remaining 14 patients
with ICVT, nine had a disability level of 1, and four
a disability level of 2. Only one patient had a dis-
ability level of 3 as a result of continued pain. That
patient, however, had no physical findings of chron-
ic venous disease. Table V shows the prevalence of
abnormal DVCTs and VRTs according to clinical
classification and venous disabilities scores.
Abnormal DVCTs and VRTs were present in nearly
all categories of clinical classifications and venous
disability scores.
DISCUSSION
At a mean follow-up of 3.4 years, 62% of patients
with ICVT were completely asymptomatic with
respect to symptoms of lower extremity chronic
Table III. Risk factors present for DVT at the time
of diagnosis of ICVT (37 patients)
No. (%)
General risk factor




Leg immobilization or paralysis 18 (48)
Congestive heart failure                                2 (5)
History of thrombosis 7 (19)
Acquired risk factors
Pregnancy/postpartum                                    2 (5)
Oral contraceptives                                      3 (8)
Coagulation disorders                                   2 (5)
Malignancy                                                 1 (3)
Dialysis-dependent                                        1 (3)
Connective tissue disorder 1 (3)
Table IV. Number (%) of venous segments with
abnormal DVCTs in patients with ICVT and in
control subjects
Patients with ICVT
Lower Lower  Control 
extremities extremities lower
Vein with ICVT without ICVT extremities 
segment (n = 38) (n = 34) (n = 34)
Common femoral 2 (5) 2 (6) 2 (6)
Popliteal 4 (11) 5 (15) 0 (0)
Posterior tibial 2 (5) 3 (9) 0 (0)
Greater saphenous 4 (11) 1 (3) 1 (3)
Lesser saphenous 2 (5) 2 (6) 0 (0)
Total 14 (7)* 13 (8)* 3 (1.7)
*p # 0.05 when compared with control subjects.
venous insufficiency. The remainder of patients had
mild symptoms possibly attributed to ICVT, with
the exception of only one patient who described sig-
nificant pain attributed to past ICVT. This patient
had both a normal physical examination and normal
venous hemodynamic testing.
Although this study is limited by the fact that
only 37 of 146 patients identified with ICVT were
studied with follow-up hemodynamic testing, it was
of course only possible to study alive patients who
could be found and would return for a follow-up
examination. As attempts were made to obtain fol-
low-up on all patients and any patient who could be
located was offered participation in the study, it is
unlikely that a systematic bias existed in patient
selection for the study. Venous hemodynamic testing
performed in this study included duplex valve clo-
sure assessment and photoplethysmographic VRT.
Air plethysmography was not used as we have previ-
ously found it to be no more sensitive in detecting
abnormalities of venous reflux than photoplethys-
mography in patients with minimal signs and symp-
toms of venous insufficiency.12 We found that 26%
of the extremities affected with ICVT had an abnor-
mal valve closure time in at least one venous seg-
ment and 23% had an abnormal VRT. The preva-
lence of these abnormalities was significantly higher
in patients than in control subjects and suggests that
limbs with ICVT, given enough time, may go on to
have more significant symptoms.
Others have found a number of late clinical
abnormalities in patients after ICVT. Lindhagen et
al.13 reported the 5-year long-term follow-up of 39
patients in whom ICVT was proved with phlebog-
raphy compared with patients with proximal DVT.
The only significant difference noted between the
two groups in follow-up was that proximal DVT
had more outflow obstruction by strain-gauge
plethysmography.13 Although no other differences
were noted between the two groups, the baseline
percentage of abnormalities in the other clinical
and vascular laboratory tests used was not provid-
ed. Others have suggested a 20% incidence of mild
to moderate venous insufficiency symptoms after
ICVT.14,15 These findings were, however, based
primarily on clinical diagnosis and follow-up of
ICVT, as both studies were performed before the
availability of color flow duplex scanning. It may be
that a number of these patients had unsuspected
proximal DVT, which erroneously suggested a
worse prognosis for ICVT. Clearly, longer follow-
up of patients with ICVT will be required to deter-
mine whether the venous hemodynamic abnormal-
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ities detected will eventually translate into more
significant manifestations of the postthrombotic
syndrome. In addition, no correlation was noted at
follow-up in the minority of patients with mild
symptoms when compared with the distribution of
vascular laboratory abnormalities. Similarly, no dif-
ferences in vascular laboratory findings were noted
at follow-up between patients treated with and
without warfarin.
It is interesting that most of the abnormalities
in duplex valve closure times detected in patients
with ICVT were in venous segments that were not
involved with thrombi at the time of duplex diag-
nosis. This finding includes extremities contralater-
al to those diagnosed with ICVT and perhaps
reflects that these patients may have had underlying
primary venous incompetence of the superficial
and deep veins beforehand and even that these may
have predisposed to ICVT. Also, because assess-
ment of reflux testing was not performed at the
time of ICVT diagnosis and the patients had only
one follow-up examination, it is of course possible
that these patients with ICVT, who averaged 2.6
risk factors for DVT, had experienced silent venous
thrombi in other locations either before or subse-
quent to the diagnosis of ICVT. It is, however,
known that patients with venous thrombosis serial-
ly followed by duplex scanning may have reflux in
venous segments that were never observed to har-
bor thrombi,16 possibly reflecting occult thrombi
at other sites or alterations in venous hemodynam-
ics induced by the occlusive process in other seg-
ments. Finally, because the peroneal veins are not
studied in our vascular laboratory protocol for
assessment of chronic venous insufficiency, we do
Table V. Prevalence of abnormal DVCTs and





0 2 (18) 4 (36)
1 3 (23) 4 (31)
2 3 (30) 2 (20)
3 2 (100) 2 (100)
4 — —
5 — —
6 1 (100) 1 (100)
Venous dysfunction disability score
0 5 (22) 8 (35)
1 3 (33) 2 (22)
2 3 (75) 3 (75)
3 0 (0) 0 (0)
4 — —
not have data on the status of the majority of the
segments that were involved with ICVT. However,
if anything, this would suggest there may be more
reflux than was detected. Although study of these
veins may have lowered the proportion of refluxing
venous segments that were not observed initially to
have been involved with thrombosis, the observa-
tion that many refluxing segments on follow-up
were not involved with thrombosis at the time of
diagnosis of ICVT is not altered.
Despite the observation that a large majority of
patients with ICVT have minimal clinical symp-
toms, the presence of detectable hemodynamic
abnormalities in the lower extremities of patients
with ICVT suggests that serial follow-up with vas-
cular laboratory examination for chronic venous
insufficiency may be prudent in deciding which
patients may benefit from elastic compression ther-
apy. Although current practice is to offer elastic
compression therapy only to symptomatic patients,
it may be that all patients with DVT may be better
off with prophylactic use of elastic stockings. A
recent report detailed the results of the use of elas-
tic compression stockings in patients in whom a
venogram documented DVT.17 Patients were ran-
domized to treatment with or without elastic
stockings. At a mean follow-up interval of 6.3
years, patients treated with elastic stockings had
significantly fewer manifestations of chronic venous
insufficiency than those treated without elastic
stockings. One can postulate that the benefits of
elastic compression therapy were most likely to
have occurred in those patients who had altered
venous hemodynamics after DVT. Indeed, others
have previously suggested that elastic stockings
may actually improve lower extremity venous
hemodynamics.18,19
Although the information contained in this
report is encouraging regarding the long-term
sequelae of ICVT, it should not be used as a basis of
minimizing ICVT. With regard to newly diagnosed
ICVT, we have recently shown that a significant
percentage of patients who have pulmonary symp-
toms and ICVT will prove to have pulmonary
emboli.2 It is also well known that as many as 20%
of acute calf vein thrombi may propagate to involve
more proximal deep veins.5 Finally, the hemody-
namic abnormalities detected in the deep veins of
the lower extremities of patients with ICVT strong-
ly argue for longer serial prospective follow-up of
these patients to better define their eventual risk of
clinical manifestations of chronic venous insuffi-
ciency.
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Dr. John Blebea (Cincinnati, Ohio). The clinical
management of patients with acute isolated calf thrombo-
sis remains controversial. Beyond the initial concerns for
propagation and embolization, Dr. McLafferty and his
associates have now provided us with helpful information
on the subsequent clinical and hemodynamic sequelae of
such thrombi. I have several comments and questions for
the authors.
This study comprised only 37 patients over a 5-year
period from two busy vascular laboratories. This raises a
concern about a potential selection bias. How many total
cases of isolated calf DVT were diagnosed during this time
period? In addition, how many of these patients under-
went follow-up duplex scans early after their initial diag-
nosis to confirm that there was no proximal progression of
thrombus and that later sequelae were actually caused by
distal rather than unrecognized proximal DVT?
In analyzing the results from this study, it should be
noted that the study and the control groups were not
completely comparable. Although the median ages were
similar the study group appears older, with 84% of patients
older than 40 years compared with only 60% of the con-
trol subjects. In addition, 19% of the study patients had a
history of DVT and an average of three ongoing risk fac-
tors for thrombosis, whereas these factors were not pre-
sent among the control group of volunteers.
The results from this study indicate that significant
hemodynamic sequelae of isolated calf DVT are limited.
Although venous recovery times were abnormal in 24% of
limbs with calf thrombi, as an indication of severity, how
shortened were these recovery times below the 18-second
upper limit of normal? Could you also speculate on why
only 8% of the contralateral limbs had prolonged venous
recovery times although 16% of these patients had a histo-
ry of proximal DVT in those limbs? These legs would have
been expected to have a greater propensity for both
abnormal venous recovery and valve closure times com-
pared with the legs with only isolated calf thrombi. In the
study limbs with just calf thrombus, the vein segments
most frequently associated with prolonged valve closure
times were not the posterior tibial veins, which had the
acute thrombi, but more proximal veins. Would this not
suggest that the abnormalities in valve closure times were
not a result of distal calf thrombi but of undiagnosed
asymptomatic proximal DVT?
The clinical sequelae of isolated calf DVT at 3 years’
follow-up were minimal. The most serious finding on
examination was leg edema without skin changes in two
patients. Significant disability was found in only one
patient, who was unable to work although he had no phys-
ical or diagnostic findings supportive of venous disease.
Because more than half of these patients were initially
treated with anticoagulation medication and 46% had
compression stockings for 7 months, were these treated
patients any less likely to later have clinical and hemody-
namic abnormalities and thus support a policy of initial
anticoagulation therapy and compression stockings in
such patients?
In summary, these data suggest that isolated calf
thrombi produce little significant early hemodynamic or
clinical morbidity. A larger series with longer follow-up
will be useful in determining whether further deterioration
occurs as a function of time.
Dr. Robert B. McLafferty. Thank you, Dr. Blebea,
for your kind comments and questions. Regarding your
first question about selection bias and the small size of our
study group, and also what the denominator was over the
time frame of study, I would agree that there is a possibil-
ity with this study for selection bias. During that time peri-
od ICVT was diagnosed in 146 patients, of whom 25%
comprised our study group. In the remaining 112
patients, approximately 50% were lost to follow-up, 25%
were deceased, and the remaining 25% refused to partici-
pate in the study.
Regarding your question of follow-up studies for prop-
agation of thrombus, 18 of our 37 patients underwent fol-
low-up examinations, and that was dependent on the order-
ing physician. Interestingly, none of these 18 patients had
any evidence of propagation. A subanalysis comparing those
with follow-up and those without follow-up showed no dif-
ference in vascular laboratory abnormalities.
Regarding your third question about the differences in
our control group with regard to age and risk, you are cor-
rect in your observation that the control group was signif-
icantly younger and had minimal risk factors. I would like
to emphasize that the purpose of our control group was to
validate our vascular laboratory. We wanted to choose sub-
jects with no venous disease and show that our vascular
laboratory was specific, thereby having minimal false posi-
tivity, and I think we did that in our study.
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In regard to your question concerning just how short-
ened the venous recovery times were in those extremities
with isolated calf vein thrombosis, we found the mean of
those 12 extremities to be 11.7 seconds, with a range of
4.5 to 17 seconds.
With regard to your question about speculating why
8% of the contralateral extremities had a normal VRT
when 16% had a previous history of proximal DVT, I
would agree that one would expect the VRTs to be short-
er in that group. Perhaps it is indicative of those extremi-
ties receiving adequate treatment, and then some of them
went on to have a normalized VRT. It should be empha-
sized that this is a small group of patients, and therefore
the difference between 18% and 16% is relatively small.
Regarding the even distribution of abnormal duplex
valve closure times in the extremities with ICVT, again I
would agree that perhaps this does represent undiagnosed
asymptomatic proximal DVT in those extremities before
or after the diagnosis of isolated calf vein thrombosis.
And your last question was an excellent one regarding
the differences in vascular laboratory findings in patients
treated with warfarin and those not treated with warfarin,
and also the differences in those treated with compression
therapy and those treated without compression therapy. As
I presented on the slide, 51% of patients were treated with
warfarin. We performed a subanalysis of this, and 50% of
the patients who were treated with warfarin had an abnor-
mal duplex valve closure time, as opposed to no patients
having an abnormal duplex valve closure time among
those patients who were not treated with warfarin. This
finding surprised us very much because it contradicts pre-
vious literature. So we went back and looked at the data,
and we found that all the patients who had pulmonary
symptoms were in the group that were treated with war-
farin. So I think we can only speculate that possibly these
patients had a greater burden of thrombus and that’s why
they had more abnormal duplex valve closure times.
In terms of compression therapy, again the same thing
was true in that 42% of those patients who were treated
with compression therapy had an abnormal duplex valve
closure time compared with only 7% in patients who were
not treated with compression therapy. And again, perhaps
this relates to patients having greater symptoms and
potentially greater clot burden at the time.
Dr. Lazar J. Greenfield (Ann Arbor, Mich.). I would
like to congratulate the authors for adding additional
information in this controversial area. In that regard,
could you expand a bit on the findings in the patients who
had pulmonary symptoms? How many of them were con-
firmed to have sustained pulmonary embolism?
The other question relates to clinical outcomes, which
has, in my experience, always seemed to relate to whether
the patients were able to ambulate with their calf vein
thrombosis or whether they were immobilized. Did you
analyze the outcomes in those two groups?
Dr. McLafferty. Thank you, Dr. Greenfield. Regarding
the pulmonary symptoms, in this specific study we did not
look to see which patients were exactly diagnosed with the
pulmonary embolism. We just categorized them as having
pulmonary symptoms that led to a diagnosis of isolated
calf vein thrombosis. In a previous paper published by our
group, we did look at that question specifically, and we
found that roughly 20% had the diagnosis of a pulmonary
embolism; and the only finding in retrospect was an iso-
lated calf vein thrombosis. So I think that it’s clear that
isolated calf vein thrombosis poses a real risk to pulmonary
embolism. As far as ambulatory patients versus nonambu-
latory patients, we did not examine these variables in the
study.
Dr. Robert L. Kistner (Honolulu, Hawaii). I want
to congratulate you on the presentation of this experience.
We also have been interested in calf deep venous throm-
bosis. Our clinical experience would support yours in that
the clots seemed to clear entirely from the tibial veins in 6
to 12 months.
As for the hemodynamic changes, I think that your
second study used the cuff deflation technique, which was
not true for your first study. If that’s true, you really only
have one time when you looked at the reflux aspect of the
patients’ extremities. So I would ask you to comment on
that because there is no way to determine progression of
disease.
The second thing I would like to ask you is whether
you have related the sequelae to the degree of thrombosis,
that is, are the sequelae of a small isolated calf vein throm-
bus different than a very extensive clot?
Dr. McLafferty. Excellent question about just a one-
time duplex valve closure time test, and I agree it would
be better to follow these patients prospectively and per-
haps see whether the second test or a third test is equiva-
lent to the first. I think that should be done.
Lastly, it is difficult to know whether the burden of
thrombus ultimately leads to more symptoms. As I stated
before, we did find in a subanalysis that those patients who
were treated with warfarin and those treated with com-
pression stockings had more duplex valve closure time
abnormalities. We did not make an attempt to quantify the
amount for thrombus present at the original examination
and then correlate it to symptoms and outcome.
